Hubei Hongyuan Pharmaceutical Technology Co., Ltd. engages in the research, development, production, sales of organic chemical raw materials, pharmaceutical intermediates, APIs and pharmaceutical preparations. It also produces lithium hexafluorophosphate, one of the main materials of lithium electrolytes. The company was founded on January 21, 2002 and is headquartered in Huanggang, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company